# Introducing the clinical trials monitor: a new section of the journal for immunotherapy of cancer

**Authors:** Leisha A. Emens, Pedro Romero

PMC · DOI: 10.1186/s40425-015-0092-y · Journal for Immunotherapy of Cancer · 2015-10-20

## Full-text entities

- **Genes:** IDO1 (indoleamine 2,3-dioxygenase 1) [NCBI Gene 3620] {aka IDO, IDO-1, INDO}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}
- **Diseases:** Cancer (MESH:D009369), toxicity (MESH:D064420)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4617860/full.md

---
Source: https://tomesphere.com/paper/PMC4617860